12117845

Source:http://linkedlifedata.com/resource/pubmed/id/12117845

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013227, umls-concept:C0030705, umls-concept:C0038951, umls-concept:C0175668, umls-concept:C0190211, umls-concept:C0948089, umls-concept:C1274040, umls-concept:C1456501, umls-concept:C1522326, umls-concept:C1524063, umls-concept:C1556084
pubmed:issue	2
pubmed:dateCreated	2002-7-15
pubmed:abstractText	There is evidence that several classes of drugs are beneficial for secondary prevention in patients with coronary artery disease.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-10395630, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-10475181, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-10498130, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-10639539, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-7586285, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-7968073, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-8298418, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-8801446, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-9347267, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-9385882, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-9708461, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-9820987, http://linkedlifedata.com/resource/pubmed/commentcorrection/12117845-9841303
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9602087
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cardiovascular Agents
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1468-201X
pubmed:author	pubmed-author:CambouJ-PJP, pubmed-author:CanterAA, pubmed-author:DanchinNN, pubmed-author:FerrièresJJ, pubmed-author:GrenierOO
pubmed:issnType	Electronic
pubmed:volume	88
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	159-62
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:12117845-Aged, pubmed-meshheading:12117845-Analysis of Variance, pubmed-meshheading:12117845-Angina, Unstable, pubmed-meshheading:12117845-Angioplasty, Balloon, Coronary, pubmed-meshheading:12117845-Cardiovascular Agents, pubmed-meshheading:12117845-Coronary Artery Bypass, pubmed-meshheading:12117845-Female, pubmed-meshheading:12117845-Hospitalization, pubmed-meshheading:12117845-Humans, pubmed-meshheading:12117845-Male, pubmed-meshheading:12117845-Myocardial Infarction, pubmed-meshheading:12117845-Retrospective Studies
pubmed:year	2002
pubmed:articleTitle	Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey.
pubmed:affiliation	Cardiologie Hôpital Européen Georges Pompidou, Paris, France. nicolas.danchin@egp.ap-hop-paris.fr
pubmed:publicationType	Journal Article